Chapter title |
Evaluation of VEGF-Induced Vascular Permeability in Mice.
|
---|---|
Chapter number | 27 |
Book title |
Permeability Barrier
|
Published in |
Methods in molecular biology, January 2011
|
DOI | 10.1007/978-1-61779-191-8_27 |
Pubmed ID | |
Book ISBNs |
978-1-61779-190-1, 978-1-61779-191-8
|
Authors |
Sara M. Weis, Weis, Sara M. |
Abstract |
Vascular endothelial growth factor (VEGF) is a potent inducer of angiogenesis and vascular leak involved in development, wound healing, tumor growth, macular degeneration, and ischemia. Studying the effects of VEGF in vitro is not always sufficient to approximate the complex in vivo response that involves multiple cell types within functioning tissues. Treating mice with an intravenous injection of recombinant VEGF produces a rapid and transient biochemical response that is accompanied by a series of ultrastructural changes. Similar events are induced by hypoxia-induced VEGF in the heart following myocardial infarction or by tumor cell-released VEGF during metastasis. Studying how intact blood vessels respond to VEGF will augment the further development of antipermeability strategies to improve disease progression in a number of pathologies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
China | 1 | 7% |
Switzerland | 1 | 7% |
Unknown | 12 | 86% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Professor | 3 | 21% |
Researcher | 3 | 21% |
Student > Master | 2 | 14% |
Student > Ph. D. Student | 2 | 14% |
Unspecified | 1 | 7% |
Other | 2 | 14% |
Unknown | 1 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 5 | 36% |
Medicine and Dentistry | 2 | 14% |
Biochemistry, Genetics and Molecular Biology | 1 | 7% |
Unspecified | 1 | 7% |
Immunology and Microbiology | 1 | 7% |
Other | 1 | 7% |
Unknown | 3 | 21% |